Risk of Anaphylaxis Among New Users of GLP-1 Receptor Agonists: A Cohort Study.
Anthony MS, Aroda VR, Parlett LE, Djebarri L, Berreghis S, Calingaert B, Beachler DC, Crowe CL, Johannes CB, Juhaeri J, Lanes S, Pan C, Rothman KJ, Saltus CW, Walsh KE.
Anthony MS, et al. Among authors: pan c.
Diabetes Care. 2024 Apr 1;47(4):712-719. doi: 10.2337/dc23-1911.
Diabetes Care. 2024.
PMID: 38363873
Free PMC article.